 Vascular Biogenics Ltd. went public after all.. The Israeli biotechnology companyâ€™s bankers, in a rare move, had canceled its initial public offering in the U.S. in August after several days of trading, citing the failure of an investor to buy stock in the offering as expected. But the deal was revived Tuesday night, with Deutsche Bank AG leading a new, smaller offering.. The...
  